Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies
Ali Murat Kahveci, Veysel Tahan
(Turk J Gastroenterol 2016; 27: 89-90) DOI: 10.5152/tjg.2015.150012
Ali Murat Kahveci, Veysel Tahan
(Turk J Gastroenterol 2016; 27: 89-90) DOI: 10.5152/tjg.2015.150012